BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31377820)

  • 1. Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer.
    de Korne CM; Wit EM; de Jong J; Valdés Olmos RA; Buckle T; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2558-2568. PubMed ID: 31377820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients.
    Buckle T; Brouwer OR; Valdés Olmos RA; van der Poel HG; van Leeuwen FW
    J Nucl Med; 2012 Jul; 53(7):1026-33. PubMed ID: 22645296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
    Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.
    KleinJan GH; van den Berg NS; de Jong J; Wit EM; Thygessen H; Vegt E; van der Poel HG; van Leeuwen FW
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1278-87. PubMed ID: 26768422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multispectral Fluorescence Imaging During Robot-assisted Laparoscopic Sentinel Node Biopsy: A First Step Towards a Fluorescence-based Anatomic Roadmap.
    van den Berg NS; Buckle T; KleinJan GH; van der Poel HG; van Leeuwen FWB
    Eur Urol; 2017 Jul; 72(1):110-117. PubMed ID: 27345689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection.
    Wit EMK; van Beurden F; Kleinjan GH; Grivas N; de Korne CM; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1743-1753. PubMed ID: 34748059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer.
    KleinJan GH; van den Berg NS; Brouwer OR; de Jong J; Acar C; Wit EM; Vegt E; van der Noort V; Valdés Olmos RA; van Leeuwen FW; van der Poel HG
    Eur Urol; 2014 Dec; 66(6):991-8. PubMed ID: 25092539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Intraoperative Fluorescence Imaging Identify All Lesions While the Road Map Created by Preoperative Nuclear Imaging Is Masked?
    Meershoek P; Buckle T; van Oosterom MN; KleinJan GH; van der Poel HG; van Leeuwen FWB
    J Nucl Med; 2020 Jun; 61(6):834-841. PubMed ID: 31712325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.
    van der Poel HG; Buckle T; Brouwer OR; Valdés Olmos RA; van Leeuwen FW
    Eur Urol; 2011 Oct; 60(4):826-33. PubMed ID: 21458154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.
    Brouwer OR; van den Berg NS; Mathéron HM; van der Poel HG; van Rhijn BW; Bex A; van Tinteren H; Valdés Olmos RA; van Leeuwen FW; Horenblas S
    Eur Urol; 2014 Mar; 65(3):600-9. PubMed ID: 24355132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Hybrid Tracer Indocyanine Green- 99m Tc-Nanocolloid for Sentinel Node Biopsy in Bladder Cancer-A Prospective Pilot Study.
    Rietbergen DDD; van Gennep EJ; KleinJan GH; Donswijk M; Valdés Olmos RA; van Rhijn BW; van der Poel HG; van Leeuwen FWB
    Clin Nucl Med; 2022 Sep; 47(9):774-780. PubMed ID: 35713891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
    Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
    J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-
    Vreeburg MTA; Azargoshasb S; van Willigen D; Molenaar T; van Oosterom MN; Buckle T; Slof LJ; Klop M; Karakullukcu B; Donswijk M; van der Poel HG; van Leeuwen FWB; Brouwer OR; Rietbergen DDD
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2282-2291. PubMed ID: 36929210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles.
    Winter A; Kowald T; Paulo TS; Goos P; Engels S; Gerullis H; Schiffmann J; Chavan A; Wawroschek F
    Int J Nanomedicine; 2018; 13():6689-6698. PubMed ID: 30425483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of pelvic lymph node metastases in prostate cancer.
    Joniau S; Van den Bergh L; Lerut E; Deroose CM; Haustermans K; Oyen R; Budiharto T; Ameye F; Bogaerts K; Van Poppel H
    Eur Urol; 2013 Mar; 63(3):450-8. PubMed ID: 22795517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.
    Ankersmit M; Hoekstra OS; van Lingen A; Bloemena E; Jacobs MAJM; Vugts DJ; Bonjer HJ; van Dongen GAMS; Meijerink WJHJ
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1495-1505. PubMed ID: 30798428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer.
    Hinsenveld FJ; Wit EMK; van Leeuwen PJ; Brouwer OR; Donswijk ML; Tillier CN; Vegt E; van Muilekom E; van Oosterom MN; van Leeuwen FWB; van der Poel HG
    J Nucl Med; 2020 Apr; 61(4):540-545. PubMed ID: 31562222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal surgical guidance towards the sentinel node in vulvar cancer.
    Mathéron HM; van den Berg NS; Brouwer OR; Kleinjan GH; van Driel WJ; Trum JW; Vegt E; Kenter G; van Leeuwen FW; Valdés Olmos RA
    Gynecol Oncol; 2013 Dec; 131(3):720-5. PubMed ID: 24051219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of the hybrid tracer indocyanine green-99mTc-nanocolloid for sentinel node biopsy in a series of patients with different lymphatic drainage patterns.
    Frontado LM; Brouwer OR; van den Berg NS; Mathéron HM; Vidal-Sicart S; van Leeuwen FW; Valdés Olmos RA
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):227-33. PubMed ID: 23567320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Node Identification with Hybrid Tracer-guided and Conventional Dynamic Sentinel Node Biopsy in Penile Cancer: A Prospective Study in 130 Patients from the Two National Referral Centres in Sweden.
    Torbrand C; Warnolf Å; Glombik D; Davidsson S; Carlsson J; Baseckas G; Håkansson U; Trägårdh E; Geijer H; Liedberg F; Kirrander P
    Eur Urol Oncol; 2022 Dec; 5(6):704-711. PubMed ID: 36272960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.